Skip to main content
Premium Trial:

Request an Annual Quote

Looking Back at Life in R&D

After 17 years at Lilly, the head of R&D at Lilly Research Laboratories Steven Paul is retiring. While speaking with R&D Directions, Paul says his accomplishments during that time include debuting three new drugs while leading the neuroscience division, redesigning the discovery aspect of the organization, and bringing in new people to keep the pipeline moving. When asked about challenges still acing the industry, Paul says is that “the industry collectively is not producing enough innovative new medicines on an annual basis to stem the loss of revenues due to patent expirations.”

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.